MDCorp seeks to drive the rollup and platform foundation for MedTech companies worldwide with a special emphasis on growing our existing footprint by extending our reach from Europe into the Asian and Pacific Rim marketplace. MDCorp acquires what it feels is leading technology in the medical equipment, diagnostic and biotech space, then works with its extensive network to develop that technology and build world class sales partnerships and grow the business organic to MDCorp. MDCorp will directly or indirectly capitalize its subsidiaries in order to drive the best economics we feel are available for each technology or solution, allowing our subsidiary managers to directly fund themselves or where appropriate or where it creates more value, use equity in MDCorp to drive investment from our corporate entity. MDCorp has long recognized that Asia is the home for more than 50% of the world’s population, yet healthcare spending per-capita remains some 75% below developed country averages. MDCorp seeks to utilize technology, distribution and brand equity to more rapidly develop med-tech and biotechnology solutions in the local market. We feel this makes MDCorp one of the most unique platforms through which we can accelerate local market product development and distribution.
SEATTLE, June 2, 2017 /PRNewswire/ -- MDCorp (OTC: MDCX) has executed an LOI to acquire 100% equity stake in Terramed, Ltd., Intellemed Ltd., Neuraxon, Ltd. hereafter described as "European Distribution Medical Systems" (EDMS). The EDMS group shall upon successful acquisition, if completed, become a wholly owned subsidiary of MDCorp.
EDMS represents a trio of European Medical distribution companies headed by Mr. Pantelis Stanitsas historically covering 6 countries in the European Union with sales channels into the United Kingdom, Greece, Cyprus, Romania, Bulgaria, and Kazakhstan. Revenues currently in the neighborhood of $5 million Euros are expected to expand with additional CAPEX funding. It is expected that our cooperation and acquisition shall allow EDMS as a wholly owned subsidiary of MDCorp to take advantage of new products and services layered across an existing, growing base of new branch offices.